Lepirudin dosing in dialysis-dependent renal failure (Q33334227)

25 July 2017

title

Lepirudin dosing in dialysis-dependent renal failure (English)

1 reference

25 July 2017

0 references

1 reference

A K Wittkowsky

1

1 reference

25 July 2017

L M Kondo

series ordinal

2

1 reference

25 July 2017

language of work or name

English

0 references

publication date

1 September 2000

1 reference

25 July 2017

1 reference

25 July 2017

volume

20

1 reference

25 July 2017

issue

9

1 reference

25 July 2017

page(s)

1123-1128

1 reference

Hirudins: from leeches to man.

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.13.1123.35039

Recombinant hirudin: genetic engineering and structure analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.13.1123.35039

Anticoagulant and Antithrombotic Actions of Recombinant Hirudin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.13.1123.35039

Monitoring of recombinant hirudin: assessment of a plasma-based ecarin clotting time assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.13.1123.35039

Heparin-induced thrombocytopenia. Pathogenesis, frequency, avoidance and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.13.1123.35039

Use of recombinant hirudin in patients with heparin-induced thrombocytopenia with thrombosis requiring cardiopulmonary bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.13.1123.35039

Cardiovascular surgery without cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II using anticoagulation with recombinant hirudin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.13.1123.35039

Recombinant hirudin: a specific thrombin inhibiting anticoagulant for hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.13.1123.35039

Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction: results from the GUSTO-IIb Trial. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coron

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.13.1123.35039

A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.13.1123.35039

A comparison between the use of recombinant hirudin and heparin during hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.13.1123.35039

A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary Syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.13.1123.35039

10.1592/PHCO.20.13.1123.35039

21 January 2018

Identifiers

DOI

1 reference

25 July 2017

1 reference